Literature DB >> 8160581

Hemodynamic deterioration during ICD implant: predictors of high-risk patients.

G Steinbeck1, U Dorwarth, S Mattke, E Hoffmann, A Markewitz, H Kaulbach, P Tassani.   

Abstract

Defibrillation threshold (DFT) testing during implantation of the cardioverter defibrillator is associated with hemodynamic deterioration and pump failure in many patients. We investigated the influence of DFT testing on cardiac function intraoperatively using a balloon-tipped catheter. In 13 consecutive patients with a nonthoracotomy approach, a mean of 3.4 +/- 1.4 episodes of ventricular fibrillation were induced with an overall ischemic time of 87 +/- 54 seconds. At the end of DFT testing, patients with a left ventricular ejection fraction (EF) of < 30% had significant impairment of cardiac index (1.6 +/- 0.5 L/min/m2 after testing vs 2.2 +/- 0.6 L/min/m2 before the procedure). One patient with severely comprised ventricular function needed prolonged positive inotropic support. The left ventricular function of patients with a preoperative EF > or = 30%, however, was not changed (2.2 +/- 0.5 L/min/m2 after testing and 2.2 +/- 0.5 L/min/m2 before testing). The two groups did not differ with respect to the number of testing episodes, ischemic time, or DFT. Thus patients with a low preoperative EF (< 30%) are threatened by a severe left ventricular deterioration during ICD implantation. Close hemodynamic monitoring with a balloon-tipped catheter is recommended in these patients.

Entities:  

Mesh:

Year:  1994        PMID: 8160581     DOI: 10.1016/0002-8703(94)90088-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

Review 1.  [Implantation of cardioverter-defibrillators. How much anesthesia is necessary?].

Authors:  T Sellmann; M Winterhalter; U Herold; P Kienbaum
Journal:  Anaesthesist       Date:  2010-06       Impact factor: 1.041

2.  [Experienced anesthetists indispensable. Anesthesia management for implantation of cardioverter/defibrillators].

Authors:  P Tassani-Prell; G Juchem
Journal:  Anaesthesist       Date:  2010-06       Impact factor: 1.041

3.  Myocardial stunning following defibrillation threshold testing.

Authors:  Michael Mollerus; Leslee Naslund
Journal:  J Interv Card Electrophysiol       Date:  2007-09-11       Impact factor: 1.900

4.  [Optimal electrode placement. What to consider during implantation of a biventricular pacemaker?].

Authors:  C Butter; H-H Minden
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-09

5.  A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study.

Authors:  Maurizio Gasparini; Carlo Menozzi; Alessandro Proclemer; Maurizio Landolina; Severio Iacopino; Angelo Carboni; Ernesto Lombardo; François Regoli; Mauro Biffi; Valeria Burrone; Alessandra Denaro; Giuseppe Boriani
Journal:  Eur Heart J       Date:  2009-06-29       Impact factor: 29.983

6.  [Influence of waveform and configuration of electrodes on the defibrillation threshold of implantable cardioverter-defibrillators].

Authors:  M Block; D Hammel; G Breithardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  1997-03

Review 7.  The Defibrillation Conundrum: New Insights into the Mechanisms of Shock-Related Myocardial Injury Sustained from a Life-Saving Therapy.

Authors:  Nicolas Clementy; Alexandre Bodin; Arnaud Bisson; Ana-Paula Teixeira-Gomes; Sebastien Roger; Denis Angoulvant; Valérie Labas; Dominique Babuty
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

8.  Defibrillation testing of the implantable cardioverter defibrillator: when, how, and by whom?

Authors:  Luis A Pires
Journal:  Indian Pacing Electrophysiol J       Date:  2007-08-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.